Results 171 to 180 of about 253,519 (319)
Constructing targeted minimum loss/maximum likelihood estimators: a simple illustration to build intuition. [PDF]
Ross RK +4 more
europepmc +1 more source
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla +9 more
wiley +1 more source
In this article, we propose an estimator-based second-order sliding mode (SOSM) controller tailored for uncertain nonlinear systems with unknown input delay.
Mengyi Zhang (7454231) +4 more
core
Assessing bias and precision in state policy evaluations: a comparative analysis of time-varying estimators using policy simulations. [PDF]
Griswold M +8 more
europepmc +1 more source
Keratin 19 (KRT19) is overexpressed in high‐grade serous ovarian cancer with high levels of Kallikrein‐related peptidases (KLK) 4–7 and is associated with poor survival. In vivo analyses demonstrate that elevated KRT19 increases peritoneal tumour burden.
Sophia Bielesch +13 more
wiley +1 more source
The Asymptotic distribution of the LIML Estimator in a Partially Identified Structural Equation [PDF]
We derive general formulae for the asymptotic distribution of the LIML estimator for the coefficients of both endogenous and exogenous variables in a partially identified linear structural equation.
Giovanni Forchini
core
Uniform in Bandwidth Consistency of the <i>L</i><sup>1</sup>-Modal Regression Estimator for High-Dimensional Data. [PDF]
Almulhim FA, Alamari MB, Laksaci A.
europepmc +1 more source
Somatic mutational landscape in von Hippel–Lindau familial hemangioblastoma
The causes of central nervous system (CNS) hemangioblastoma in Von Hippel–Lindau (vHL) disease are unclear. We used Whole Exome Sequencing (WES) on familial hemangioblastoma to investigate events that underlie tumor development. Our findings suggest that VHL loss creates a permissive environment for tumor formation, while additional alterations ...
Maja Dembic +5 more
wiley +1 more source
On the Inclusion of Non-Concurrent Controls in Platform Trials With an Interim Analysis. [PDF]
Krotka P, Posch M, Bofill Roig M.
europepmc +1 more source
We have established a humanized orthotopic patient‐derived xenograft (Hu‐oPDX) mouse model of high‐grade serous ovarian cancer (HGSOC) that recapitulates human tumor–immune interactions. Using combined anti‐PD‐L1/anti‐CD73 immunotherapy, we demonstrate the model's improved biological relevance and enhanced translational value for preclinical ...
Luka Tandaric +10 more
wiley +1 more source

